↓ Skip to main content

COX-2 overexpression in resected pancreatic head adenocarcinomas correlates with favourable prognosis

Overview of attention for article published in BMC Cancer, June 2014
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (62nd percentile)
  • Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

twitter
3 tweeters

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
37 Mendeley
Title
COX-2 overexpression in resected pancreatic head adenocarcinomas correlates with favourable prognosis
Published in
BMC Cancer, June 2014
DOI 10.1186/1471-2407-14-458
Pubmed ID
Authors

Ewa Pomianowska, Aasa R Schjølberg, Ole Petter F Clausen, Ivar P Gladhaug

Abstract

Overexpression of cyclooxygenase-2 (COX-2) has been implicated in oncogenesis and progression of adenocarcinomas of the pancreatic head. The data on the prognostic importance of COX expression in these tumours is inconsistent and conflicting. We evaluated how COX-2 overexpression affected overall postoperative survival in pancreatic head adenocarcinomas.

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 37 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 5%
Unknown 35 95%

Demographic breakdown

Readers by professional status Count As %
Student > Master 3 8%
Student > Ph. D. Student 1 3%
Student > Doctoral Student 1 3%
Other 1 3%
Student > Postgraduate 1 3%
Other 0 0%
Unknown 30 81%
Readers by discipline Count As %
Medicine and Dentistry 7 19%
Unknown 30 81%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 March 2015.
All research outputs
#2,008,423
of 4,855,319 outputs
Outputs from BMC Cancer
#675
of 2,724 outputs
Outputs of similar age
#43,742
of 123,012 outputs
Outputs of similar age from BMC Cancer
#26
of 142 outputs
Altmetric has tracked 4,855,319 research outputs across all sources so far. This one has received more attention than most of these and is in the 56th percentile.
So far Altmetric has tracked 2,724 research outputs from this source. They receive a mean Attention Score of 2.6. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 123,012 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.
We're also able to compare this research output to 142 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.